.FDA rejects psychedelic MDMA-assisted therapy for PTSD NBC NewsF.D.A. Decreases to Authorize MDMA Treatment, Seeking Even More Research Study The Nyc TimesFDA Declines Ecstasy-Based Drug The Stock market JournalFDA declines to accept novel MDMA therapy to manage post-traumatic stress disorder, along with request for more litigation data CNNFDA rejects initially experimental to manage PTSD, asking for more research The Washington Article.